SCRIBE

Scribe Therapeutics Inc.

Application Filed: 2018-11-09
Trademark Application Details
Trademark Logo SCRIBE

Mark For: SCRIBE® trademark registration is intended to cover the categories of pharmaceutical and biological preparations based on genetic engineering and gene therapy for use in diagnosis, prevention, and treatment of diseases in human therapeutics; Gene therapy products, namely, biological preparations based on engineered cells for medical use in immuno oncology, degenerative disorders, traumatic injury, enzyme replacement therapy, and immunology; Pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics; Pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders, including neurological disorders, Huntington's disease, amyotrophic lateral sclerosis (ALS), front temporal dementia, pain, Alzheimer's, Parkinson's, ataxia, autism, epilepsy, pain, and also including cardiovascular, peripheral nervous system, cancer, endocrine, gastrointestinal, renal, genetic immunological, hepatic, infectious, inflammatory, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, respiratory, urogenital, urological, hematologic and viral or bacterial diseases and disorders. [all]

Status

2021-04-06 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88188800
Registration Number6775193
Mark Literal ElementsSCRIBE
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK. SERVICE MARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2020-03-26
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameJeffrey H. Greene
Attorney Docket Number333322.20000
Law Office AssignedM50
Employee NameHWANG, JOHN C B

Timeline

2018-11-09Application Filed
2019-03-26Published
2019-03-26Published for Opposition
2019-09-19Location: TMEG LAW OFFICE 105
2019-10-18Status: Live/Pending
2019-10-22Transaction Date
2020-03-26Location: INTENT TO USE SECTION
2020-11-09Status: A third request for extension of time to file a Statement of Use has been granted.
2022-06-28Trademark Registered

Trademark Parties (Applicants & Owners)

Party: Scribe Therapeutics Inc.
Address1150 Marina Village Parkway Alameda, CALIFORNIA UNITED STATES 94501
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

DrawingIMAGE/JPEG2018-11-09
TEAS RF New ApplicationMULTI2018-11-09
XSearch Search SummaryXML2019-02-14
TRAM Snapshot of App at Pub for OppostnMULTI2019-02-15
Notice of PublicationXML2019-03-06
Notification Of Notice of PublicationXML2019-03-06
OG Publication ConfirmationAPPLICATION/XML2019-03-26
Notice of AllowanceXML2019-05-21
Withdrawal of Attorney - firm retainsXML2019-09-16
Amendment and Mail Process CompleteAPPLICATION/XML,IMAGE/JPEG2019-09-20
Extension of Time to File SOUXML2019-10-18
ITU Extension ApprovalXML2019-10-22
ITU Unit ActionMULTI2019-10-22
Change Address or Representation FormXML2020-03-03
Amendment and Mail Process CompleteMULTI2020-03-27
Extension of Time to File SOUXML2020-04-17
ITU Extension ApprovalXML2020-04-21
ITU Unit ActionMULTI2020-04-21
Extension of Time to File SOUAPPLICATION/XML2020-11-09
ITU Extension ApprovalAPPLICATION/XML2020-11-11
ITU Unit ActionAPPLICATION/XML,IMAGE/JPEG2020-11-11

Attorney of Record

Jeffrey H. Greene
COOLEY LLP
1299 PENNSYLVANIA AVENUE, NW, STE. 700
WASHINGTON, DC 20004

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical and biological preparations based on genetic engineering and gene therapy for use in diagnosis, prevention, and treatment of diseases in human therapeutics; Gene therapy products, namely, biological preparations based on engineered cells for medical use in immuno oncology, degenerative disorders, traumatic injury, enzyme replacement therapy, and immunology; Pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics; Pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders, including neurological disorders, Huntington's disease, amyotrophic lateral sclerosis (ALS), front temporal dementia, pain, Alzheimer's, Parkinson's, ataxia, autism, epilepsy, pain, and also including cardiovascular, peripheral nervous system, cancer, endocrine, gastrointestinal, renal, genetic immunological, hepatic, infectious, inflammatory, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, respiratory, urogenital, urological, hematologic and viral or bacterial diseases and disorders
IC 042. US 100 101. G & S: Scientific and medical research in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering research and development of pharmaceuticals, biological preparations, diagnostic and therapeutic products and services; design and development of engineered cells for use in scientific research and drug discovery and development; Providing medical research and scientific research information in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering
IC 044. US 100 101. G & S: Molecular diagnostic services for medical purposes and medical research purposes; Medical diagnostic testing services in the field of human disease and human medical conditions

International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:42
U.S. Codes:100,101
International Codes:44
U.S. Codes:100,101
Type CodeType
GS0051Pharmaceutical and biological preparations based on genetic engineering and gene therapy for use in diagnosis, prevention, and treatment of diseases in human therapeutics; Gene therapy products, namely, biological preparations based on engineered cells for medical use in immuno oncology, degenerative disorders, traumatic injury, enzyme replacement therapy, and immunology; Pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics; Pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders, including neurological disorders, Huntington's disease, amyotrophic lateral sclerosis (ALS), front temporal dementia, pain, Alzheimer's, Parkinson's, ataxia, autism, epilepsy, pain, and also including cardiovascular, peripheral nervous system, cancer, endocrine, gastrointestinal, renal, genetic immunological, hepatic, infectious, inflammatory, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, respiratory, urogenital, urological, hematologic and viral or bacterial diseases and disorders
GS0421Scientific and medical research in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering research and development of pharmaceuticals, biological preparations and therapeutic products and services; design and development of engineered cells for use in scientific research and drug discovery and development; Providing medical research and scientific research information in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering

Trademark Filing History

DescriptionDateProceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-11-11
TEAS EXTENSION RECEIVED2020-11-09
EXTENSION 3 GRANTED2020-11-0998765
EXTENSION 3 FILED2020-11-0998765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-04-21
TEAS EXTENSION RECEIVED2020-04-17
EXTENSION 2 GRANTED2020-04-1798765
EXTENSION 2 FILED2020-04-1798765
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2020-03-2676538
CASE ASSIGNED TO INTENT TO USE PARALEGAL2020-03-2576538
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS2020-03-03
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2020-03-03
TEAS CHANGE OF OWNER ADDRESS RECEIVED2020-03-03
TEAS CHANGE OF CORRESPONDENCE RECEIVED2020-03-03
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2020-03-03
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2020-03-0388888
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2019-10-22
TEAS EXTENSION RECEIVED2019-10-18
EXTENSION 1 GRANTED2019-10-1898765
EXTENSION 1 FILED2019-10-1898765
ASSIGNED TO LIE2019-09-1973797
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2019-09-1973797
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS2019-09-16
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2019-05-21
PUBLISHED FOR OPPOSITION2019-03-26
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-03-26
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-03-06
APPROVED FOR PUB - PRINCIPAL REGISTER2019-02-14
ASSIGNED TO EXAMINER2019-02-1376843
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-11-28
NEW APPLICATION ENTERED IN TRAM2018-11-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed